Penumbra

PricePenumbra

PEN

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Historical stock price chart and annual return over the past years

2%

5 years

% Total

PEN
0%

5 years

Annual Return

PEN